The technology appraisal committees are standing advisory committees of NICE. This topic was considered by members of the existing standing committees who have met to reconsider drugs funded by the Cancer Drugs Fund. The names of the members who attended are in the minutes of the appraisal committee meeting, which are posted on the NICE website.
Committee members are asked to declare any interests in the technology to be appraised. If it is considered there is a conflict of interest, the member is excluded from participating further in that appraisal.
Each technology appraisal is assigned to a team consisting of an associate director, 1 or more health technology analysts (who act as technical leads for the appraisal), a technical adviser and a project manager.
Cancer Drugs Fund reconsideration of TA189
Martyn Burke, Henry Edwards